Neurio

Neurio is a neuroscience-focused technology company that develops advanced AI-driven solutions for brain health monitoring and diagnostics. The company's primary offering is a platform that utilizes artificial intelligence to analyze neuroimaging data, such as MRI scans, to identify early biomarkers of neurodegenerative conditions like Alzheimer's disease. By providing clinicians with automated, high-precision insights, Neurio aims to facilitate earlier intervention and more personalized treatment plans for patients with cognitive decline. Their technology is designed to integrate seamlessly into existing clinical workflows, enhancing the accuracy and efficiency of neurological assessments.